Skip to main content
NIH funding notice RFA-DK-18-004

Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)

Closed on May 10, 2018.

Posted
February 15, 2018
Close date
May 10, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,716,933 in first-year total cost, median $420,944.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-G (O3)]7

Most frequent institutions

  1. JOSLIN DIABETES CENTER1
  2. MEDICAL UNIVERSITY OF SOUTH CAROLINA1
  3. RICE UNIVERSITY1
  4. SALK INSTITUTE FOR BIOLOGICAL STUDIES1
  5. UNIVERSITY OF BRITISH COLUMBIA1
Competing awards under RFA-DK-18-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Engineering human islet-like organoids for transplantation1R01DK120480-01EVANS, RONALD MSALK INSTITUTE FOR BIOLOGICAL STUDIES, CA$865,800ZDK1
2018“Synthesis and High‐Throughput In Vivo Characterization of Alginate Encapsulation Materials for Long‐Term Islet”1R01DK120459-01VEISEH, OMIDRICE UNIVERSITY, TX$698,475ZDK1
2018Novel Gene and Stem Cell Therapy for Type 1 Diabetes1R01DK120394-01WANG, HONGJUNMEDICAL UNIVERSITY OF SOUTH CAROLINA, SC$553,150ZDK1
2018Functional Validation of Gene Modifications that Protect Beta Cells against Autoimmunity Identified by Genome-Wide CRISPR Cas9 Screening1R01DK120445-01KISSLER, STEPHANYI, PENGJOSLIN DIABETES CENTER, MA$420,944ZDK1
2018Engineering Stem Cells for Islet Cell Replacement1R01DK120392-01KIEFFER, TIMOTHY JAMESUNIVERSITY OF BRITISH COLUMBIA, BC$401,894ZDK1
2018Alpha cells conversion to beta cells in non-human primates1R01DK120377-01GITTES, GEORGE K.UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$391,250ZDK1
2018Improving human pluripotent stem cell derived beta cell transplantation using genetic lineage tracing.1R01DK120444-01RUSS, HOLGER A.UNIVERSITY OF COLORADO DENVER, CO$385,420ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DK-18-004: Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) | ScienceDex | ConductScience